Atossa Operating Cycle from 2010 to 2026
| ATOS Stock | USD 4.30 0.00 0.00% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 21.2 K | Current Value 35.5 K | Quarterly Volatility 117.4 K |
Check Atossa Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Atossa Genetics' main balance sheet or income statement drivers, such as Other Operating Expenses of 33.4 M, Research Development of 17 M or Total Operating Expenses of 33.4 M, as well as many indicators such as Price To Sales Ratio of 7.8 K, Dividend Yield of 0.0 or PTB Ratio of 1.82. Atossa financial statements analysis is a perfect complement when working with Atossa Genetics Valuation or Volatility modules.
Atossa | Operating Cycle | Build AI portfolio with Atossa Stock |
The evolution of Operating Cycle for Atossa Genetics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Atossa Genetics compares to historical norms and industry peers.
Latest Atossa Genetics' Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Atossa Genetics over the last few years. It is Atossa Genetics' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Atossa Genetics' overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Atossa Operating Cycle Regression Statistics
| Arithmetic Mean | 118,978 | |
| Geometric Mean | 19,627 | |
| Coefficient Of Variation | 98.70 | |
| Mean Deviation | 113,333 | |
| Median | 35,497 | |
| Standard Deviation | 117,437 | |
| Sample Variance | 13.8B | |
| Range | 239.3K | |
| R-Value | 0.17 | |
| Mean Square Error | 14.3B | |
| R-Squared | 0.03 | |
| Significance | 0.51 | |
| Slope | 4,003 | |
| Total Sum of Squares | 220.7B |
Atossa Operating Cycle History
About Atossa Genetics Financial Statements
Atossa Genetics shareholders use historical fundamental indicators, such as Operating Cycle, to determine how well the company is positioned to perform in the future. Although Atossa Genetics investors may analyze each financial statement separately, they are all interrelated. The changes in Atossa Genetics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Atossa Genetics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 21.2 K | 35.5 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.